A systematic review on deep learning-based automated cancer diagnosis models.

Authors:
Tandon R; Agrawal S; Rathore NPS; Mishra AK; Jain SK.

Journal:
J Cell Mol Med

Publication Year: 2024

DOI:
10.1111/jcmm.18144

PMCID:
PMC10906380

PMID:
38426930

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Cell Mol Med

Abbreviation: J Cell Mol Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Adenine base editor-based correction of the cardiac pathogenic Lmna c.1621C > T mutation in murine …
Yang L; Liu Z; Sun J and 3 more (2024) - Transparency Score: 4/6
Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
Wang M; Meng J; Wang H and 2 more (2024) - Transparency Score: 4/6
Construction of endothelial cell signatures for predicting the diagnosis, prognosis and immunothera…
Fu Y; Sun S; Shi D and 1 more (2024) - Transparency Score: 4/6
C-X-C chemokine receptor type 4 promotes tubular cell senescence and renal fibrosis through β-caten…
Wu Q; Chen Q; Xu D and 12 more (2024) - Transparency Score: 3/6
EEBR induces Caspase-1-dependent pyroptosis through the NF-κB/NLRP3 signalling cascade in non-small…
Zhao X; Chen C; Han W and 11 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors confirm that there are no conflicts of interest."

Evidence found in paper:

"FUNDING INFORMATION ‘This research received no external funding’."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025